Agenus (AGEN) Net Cash Flow (2010 - 2026)
Agenus (AGEN) posted quarterly Net Cash Flow of $32.0 million for Q1 2026, up 245.71% year-over-year from $9.3 million in Q1 2025, and up 6998.49% quarter-over-quarter from -$464000.0 in Q4 2025.
Agenus (AGEN) Net Cash Flow (2010 - 2026) Analysis & Trends
Agenus' Net Cash Flow history runs 17 years deep, the most recent figure standing at $32.0 million for Q1 2026.
- In Q1 2026, Net Cash Flow rose 245.71% year-over-year to $32.0 million; the TTM figure through Mar 2026 stood at $14.6 million (up 142.49% YoY), while the FY2025 annual figure was -$39.4 million, down 11.17% from the prior year.
- Net Cash Flow for Q1 2026 stood at $32.0 million, up from -$464000.0 in the prior quarter.
- The five-year high for Net Cash Flow was $40.7 million in Q2 2024, with the low at -$48.7 million in Q3 2024.
- The 5-year median for Net Cash Flow is -$19.7 million (2022), against an average of -$15.1 million.
- The sharpest annual moves came in 2022 and 2024: Net Cash Flow tumbled 319.19% in 2022, then jumped 291.25% in 2024.
- Agenus' Net Cash Flow stood at -$29.9 million in 2022, then retreated by 1.05% to -$30.3 million in 2023, then surged by 85.78% to -$4.3 million in 2024, then jumped by 89.22% to -$464000.0 in 2025, then jumped by 6998.49% to $32.0 million in 2026.
- Business Quant data shows AGEN's Net Cash Flow at $32.0 million in Q1 2026, -$464000.0 in Q4 2025, and -$8.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | -16.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.25 Mn |
| Jun 30, 2026 | -16.25 Mn |
| Mar 31, 2026 | 32.01 Mn |
| Mar 31, 2026 | 32.01 Mn |
| Dec 31, 2025 | -464,000.00 |
| Dec 31, 2025 | -464,000.00 |
| Sep 30, 2025 | -7.98 Mn |
| Sep 30, 2025 | -7.98 Mn |
| Jun 30, 2025 | -9.00 Mn |
| Jun 30, 2025 | -9.00 Mn |
| Mar 31, 2025 | -21.97 Mn |
| Mar 31, 2025 | -21.97 Mn |
| Dec 31, 2024 | -4.30 Mn |
| Dec 31, 2024 | -4.30 Mn |
| Sep 30, 2024 | -48.68 Mn |
| Sep 30, 2024 | -48.68 Mn |
| Jun 30, 2024 | 40.67 Mn |
| Jun 30, 2024 | 40.67 Mn |
| Mar 31, 2024 | -23.13 Mn |
| Mar 31, 2024 | -23.13 Mn |